Skin tissue that has atrophied or changed due to aging, trauma, congenital etc.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals who meet all of the following criteria Have clear tissue deformity or atrophy due to congenital conditions, trauma, or aging Are expected to benefit from this treatment Wish to receive the treatment and have been deemed suitable for it by a physician Are able to attend outpatient visits adults Have provided written informed consent for this treatment
Exclusion criteria
Exclusion criteria: Have a clearly apparent infection in the area surrounding the injection site Have a predisposition to keloid formation Have an insufficient understanding of this treatment Lack the capacity to make an informed decision regarding this treatment Do not wish to receive this treatment or are unable to provide informed consent Are deemed inappropriate for the treatment by the physician, such as those with malignant tumors, infectious tumors, infectious diseases, or inflammatory diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Photographs and a patient satisfaction survey will be conducted at 1 month, 3 months, and 6 months after the start of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| At 2 weeks and 1 month following the start of treatment, image analysis will be conducted with the neoVoir imaging system. | — |
Countries
Japan
Contacts
Tokyo Chuo Beauty Clinic (TCB), BS Clinic, Umeda Osaka Ekimae Branch Tokyo Chuo Beauty Clinic (TCB), BS Clinic, Umeda Osaka Ekimae Branch